NCT00330317 - Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

November 16, 2010

Conditions

Breast Cancer

Interventions

DRUG

letrozole

2.5mg letrozole once-daily

Trial Locations (20)

Novartis Investigative Site, Bournemouth

Novartis Investigative Site, Brighton

Novartis Investigative Site, Bristol

Novartis Investigative Site, Crewe

Novartis Investigative Site, Dundee

Novartis Investigative Site, East Sussex

Novartis Investigative Site, Epping

Novartis Investigative Site, Farnworth

Novartis Investigative Site, Gateshead

Novartis Investigative Site, Glasgow

Novartis Investigative Site, Hants

Novartis Investigative Site, Leicester

Novartis Investigative Site, Liverpool

Novartis Investigative Site, London

Novartis Investigative Site, Luton

Novartis Investigative Site, Manchester

Novartis Investigative Site, Newcastle

Novartis Investigative Site, Poole

Novartis Investigative Site, Saint Leonards-on-Sea

Novartis Investigative Site, West Smithfield